Mirae Asset Global Investments Co., Ltd. Roivant Sciences Ltd. Transaction History

Mirae Asset Global Investments Co., Ltd.

$28 Billion
Q2 2025

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 26,261 shares of ROIV stock, worth $465,870. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,261

Previous 23,876 9.99%

Holding current value

$465,870

Previous $240,000 22.92%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 21, 2025	BUY	$9.08 - $11.62 $21,655 - $27,713	2,385 Added 9.99%	26,261 $295,000
Q1 2025 Apr 24, 2025	SELL	$10.09 - $12.08 $3,854 - $4,614	-382 Reduced 1.57%	23,876 $240,000
Q4 2024 Jan 27, 2025	SELL	$11.16 - $12.71 $27,777 - $31,635	-2,489 Reduced 9.31%	24,258 $286,000
Q3 2024 Oct 23, 2024	BUY	$10.17 - $12.5 $47,717 - $58,650	4,692 Added 21.27%	26,747 $308,000
Q2 2024 Jul 30, 2024	SELL	$10.36 - $11.74 $288,080 - $326,454	-27,807 Reduced 55.77%	22,055 $233,000
Q1 2024 May 01, 2024	SELL	$9.87 - $11.8 $12,909 - $15,434	-1,308 Reduced 2.56%	49,862 $525,000
Q4 2023 Jan 24, 2024	BUY	$8.38 - $11.58 $86,473 - $119,494	10,319 Added 25.26%	51,170 $574,000
Q3 2023 Oct 26, 2023	SELL	$9.76 - $13.19 $9,067 - $12,253	-929 Reduced 2.22%	40,851 $477,000
Q2 2023 Aug 10, 2023	SELL	$7.09 - $10.08 $36,775 - $52,284	-5,187 Reduced 11.04%	41,780 $421,000
Q1 2023 May 04, 2023	BUY	$6.92 - $9.98 $197,974 - $285,517	28,609 Added 155.84%	46,967 $346,000
Q4 2022 Feb 09, 2023	BUY	$3.36 - $7.99 $61,682 - $146,680	18,358 New	18,358 $146,000

Others Institutions Holding ROIV

# of Institutions

361

Shares Held

456M

Call Options Held

8.36M

Put Options Held

760K

View Full List

About Roivant Sciences Ltd.

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $12.5B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

More about ROIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Roivant Sciences Ltd. Transaction History